Citi Spots Firm Demand for Chinese AI IPOs Despite Valuation Pushback

Citi's latest note flags steady institutional interest in Chinese AI IPOs even as some investors flag lofty valuations. The bank sees buyers stepping in for shares tied to artificial intelligence hardware and software plays.

Why Demand Holds Up for These Listings

Recent filings point to strong order books from long-only funds and sovereign wealth accounts. One deal already saw allocations trimmed after oversubscription in the bookbuild phase. That pattern matches what happened with earlier semiconductor-related offerings last year.

Numbers back it up.

Historical parallels sit close at hand. During the 2021 wave of Chinese tech listings, valuation pushback surfaced early but rarely derailed final pricing when underlying revenue growth cleared double digits. The current AI cohort shows similar top-line momentum, Citi notes, even if margins remain thin in some cases.

Market Reaction So Far

Shares in listed Chinese AI peers have held their ground through recent sessions. The broader tech sector took a hit on tariff headlines last month yet the AI names recovered faster than the index. Volume in the names stays above the three-month average, suggesting the interest Citi describes is already visible on screens.

If you've been watching Hong Kong listings closely, the pattern feels familiar. Secondary trading in recently listed AI names has stayed tight, with little sign of the usual post-IPO flip selling that plagued 2022 deals.

Questions That Remain Open

Regulatory overhang from Beijing still sits in the background. Any fresh round of data-security reviews could slow timelines or force structure changes that spook foreign money. US export controls on advanced chips add another layer of uncertainty that Citi flags but does not quantify.

Still, the bank sees enough conviction among buyers to keep the pipeline active. Pricing discipline will matter. A single deal that clears at a premium and then weakens in secondary trading could shift sentiment quickly. No one on the desk is calling for a rerun of the 2020-21 frenzy, but the tone suggests caution rather than outright skepticism.

Anyone positioned in these names should keep an eye on follow-through volume after the next two or three listings clear. A quick fade would tell a different story than the current bookbuild data. There's no guarantee the appetite lasts if macro conditions deteriorate further.